Latest News - Skin Cancer

Thursday, March 21, 2019

Biofrontera Reports Positive Phase 3 Results with Ameluz for PDT of AKs on Extremities and Trunk/Neck

Results for the primary endpoint of Biofrontera AG's Phase 3 clinical trial evaluating the safety and efficacy of conventional photodynamic therapy (PDT) with Ameluz and the BF-RhodoLED lamp for t…

Read the full story

Wednesday, March 20, 2019

Are Skin Diseases More Common Than Previously Held?

Skin diseases may be more common than previously believed, according to a new study in the Journal of the European Academy of Dermatology and Venereology that estimates the prevalence of skin diseases…

Read the full story

Friday, March 15, 2019

Constellation Alpha Capital Corp. Signs Letter of Intent to Acquire DermTech, Inc.

Constellation Alpha Capital Corp., a special purpose acquisition company, has executed a non-binding Letter of Intent to merge with DermTech, Inc., a molecular genomics company with an initial focus o…

Read the full story

Monday, March 04, 2019

Almirall: Positive Data for KX2-391 for AKs; ThermiGen to be Divested

Results from two Phase III studies of KX2-391, also known as KX-01 ointment,  in the treatment of actinic keratosis show positive results. The findings have been presented at the 2019 Americ…

Read the full story

Friday, March 01, 2019

Arkansas Gets SUNucated

Arkansas has joined 18 other states in adopting legislation to allow children to possess and apply sunscreen at school. Governor Asa Hutchinson signed into law HB 1167, which was co-sponsored by Re…

Read the full story

Monday, February 25, 2019

FDA Proposes New Sunscreen Regulations; Experts React

The FDA is updating its position on over-the-counter sunscreens, and according to the new proposal, several popular ingredients require more data. New guidelines do, however, note that zinc oxide…

Read the full story

Thursday, February 14, 2019

New Guidelines Offer SRT Treatment Recommendations for Skin Cancers, Keloids

Superficial Radiation Therapy (SRT) should be first-line therapy for appropriate non-melanoma skin cancers in appropriate patients, according to new consensus guidelines published in The Journal …

Read the full story

Wednesday, February 13, 2019

Study Shows 97% Cure Rate for Superficial Radiation Therapy for BCC and SCC

A new retrospective study shows a high cure rate exceeding 97 percent among older patients (mean age: 82.5 years) being treated for basal cell carcinoma (BCC) and squamous cell carcinomas (SCC) on the…

Read the full story

Friday, February 08, 2019

Immunotherapy Appears Better Than Chemotherapy for Aggressive Merkle Cell Carcinoma

First-line therapy with Pembrolizumab may produce better responses and result in longer survival in Merkel cell carcinoma than conventional chemotherapy. The study, co-led by Suzanne Topalian, M.D.…

Read the full story

Thursday, February 07, 2019

Key West Bans Sunscreens with Oxybenzone and Octinoxate

Following Hawaii’s lead, Florida’s Key West City Commission voted to ban the sale of products that contain oxybenzone or octinoxate -- two chemicals in sunscreen that have been shown to …

Read the full story

Tuesday, January 15, 2019

Study: States with Fewer Melanoma Diagnoses Have Higher Death Rates

States with fewer melanoma diagnoses actually have higher death rates, report researchers at University of Utah Health. The researchers conducted a state-by-state analysis to understand the geograp…

Read the full story

Thursday, January 03, 2019

Bristol-Myers Squibb to Acquire Celgene

Bristol-Myers Squibb Company will acquire Celgene Corp. in a cash and stock transaction with an equity value of approximately $74 billion. The combined company with complementary areas of focus, will …

Read the full story

Tuesday, December 18, 2018

New Study Seeks to Improve Skin Cancer Prevention in Young Adults Via a New Website

Researchers out of Rutgers Cancer Institute of New Jersey and colleagues from across the country are conducting a study to evaluate the reach and effectiveness of an online program targeted at skin ca…

Read the full story

Friday, December 07, 2018

Naked Eye, Smart Phone Apps May Miss Melanomas

The naked eye alone is not enough to accurately diagnosis skin cancer and smart phone apps may also miss melanomas, according to a new review published in The Cochrane Library as part of a Special Col…

Read the full story

Thursday, December 06, 2018

Low 3% Keloid Recurrence Found in Multicenter Case Series of Patients Treated with SRT

Sensus Healthcare, Inc., a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radiation Therapy (IGSRT), sh…

Read the full story
Load More